MSN Group launches Fesobig to treat urinary incontinence and overactive bladder
It is first-line therapy recommended by various international treatment guideline for overactive bladder (OAB)
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Overactive Bladder
Lupin receives tentative US FDA approval for Mirabegron ER Tablets
Lupin’s Mirabegron ER Tablets, 25 mg and 50 mg, is a generic version of Myrbetriq Extended Release Tablets, 25 mg and 50 mg, of…